AddLife Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Fredrik Dalborg

Chief Executive Officer (CEO)

kr6.0m

Compensación total

Porcentaje del salario del CEO	31.6%
Permanencia del CEO	2yrs
Participación del CEO	0.02%
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	8.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Fredrik Dalborg en comparación con los beneficios de AddLife?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2023	n/a	n/a	kr292m
Jun 30 2023	n/a	n/a	kr387m
Mar 31 2023	n/a	n/a	kr429m
Dec 31 2022	kr6m	kr2m	kr480m

Compensación vs. Mercado: La compensación total de Fredrik($USD591.46K) está por debajo de la media de empresas de tamaño similar en el mercado UK ($USD2.31M).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Fredrik con los resultados de la empresa.

CEO

Fredrik Dalborg (51 yo)

2yrs

Permanencia

kr5,991,000

Compensación

Mr. Fredrik Dalborg serves as President & Chief Executive Officer at AddLife AB (publ) since 2022. Mr. Dalborg served as Managing Director for North America at Xvivo Perfusion AB (publ) since December 15,...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Fredrik Dalborg	President & CEO	2yrs	kr5.99m	0.018% SEK 2.3m
Christina Rubenhag	Chief Financial Officer	2yrs	sin datos	0.0029% SEK 382.6k
Peter Simonsbacka	Chief Commercial Officer	less than a year	sin datos	0.060% SEK 8.0m
Christian Karlsson	Head of Business Development	3yrs	sin datos	sin datos
Per Wahlstedt	Head of Business Control	2yrs	sin datos	sin datos
Timmy Rosendal	Head of Sustainability	less than a year	sin datos	sin datos
Ioana Dragan	Head of Financial Control	less than a year	sin datos	sin datos
Jamilah Wass	Group Financial Controller	no data	sin datos	sin datos
Nichlas Essner	Group Business Controller	less than a year	sin datos	sin datos
Malin Lindh	Group Business Controller	less than a year	sin datos	sin datos

0.8yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de ALIFBS no se considera experimentado ( 0.8 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Birgit Norinder	Independent Director	8.3yrs	kr350.00k	0.010% SEK 1.4m
Eva Elmstedt	Independent Director	2.7yrs	kr350.00k	0.0025% SEK 327.9k
Johan Sjo	Independent Chairman	8.8yrs	kr700.00k	0.14% SEK 18.1m
Håkan Roos	Independent Director	8.5yrs	kr350.00k	4.5% SEK 600.1m
Eva Nilsagard	Independent Director	8.1yrs	kr430.00k	0.0046% SEK 609.2k
Stefan Hedelius	Independent Director	8.3yrs	kr350.00k	0.024% SEK 3.2m

8.3yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de ALIFBS se considera experimentada (8.3 años de antigüedad promedio).

AddLife Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

AddLife AB (publ), Annual General Meeting, May 08, 2024

Independent Director recently bought kr12m worth of stock

President & CEO recently bought kr129k worth of stock

President & CEO recently bought kr139k worth of stock

President & CEO recently bought kr112k worth of stock

President & CEO recently bought kr285k worth of stock

Recent updates

AddLife AB (publ) Approves Dividend, Payable on 16 May 2024

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

AddLife AB (publ), Annual General Meeting, May 08, 2024

Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022)

Independent Director recently bought kr12m worth of stock

Investor sentiment improves as stock rises 37%

President & CEO recently bought kr129k worth of stock

Addlife AB (Publ) Declares Dividend

Upcoming dividend of kr1.20 per share at 1.0% yield

President & CEO recently bought kr139k worth of stock

President & CEO recently bought kr112k worth of stock

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

President & CEO recently bought kr285k worth of stock

Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million.

AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023

Second quarter 2022 earnings released

Now 23% undervalued after recent price drop

Investor sentiment deteriorated over the past week

CFO & Business Area Manager of Medtech recently sold kr8.5m worth of stock

Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022

AddLife AB (publ) Appoints Fredrik Dalborg as President

Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020)

AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited.

Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring.

President & CEO recently bought kr5.8m worth of stock

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Addlife AB (Publ) Proposes Dividend

Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer

AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity.

Investor sentiment deteriorated over the past week

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring.

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

President & CEO recently sold kr32m worth of stock

Third quarter 2021 earnings released

Investor sentiment deteriorated over the past week

Independent Chairman recently sold kr11m worth of stock

AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV.

Investor sentiment improved over the past week

Chief Financial Officer recently sold kr106k worth of stock

Independent Chairman recently sold kr7.0m worth of stock

Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020)

Investor sentiment improved over the past week

Chief Financial Officer recently sold kr14m worth of stock

Independent Director has left the company

AddLife AB (publ) Approves Dividend, Payable on 12 May 2021

First quarter 2021 earnings released

Upcoming dividend of kr1.50 per share

AddLife AB (Publ) Provides Earnings Guidance for 2021

New 90-day high: kr175

Full year 2020 earnings released: EPS kr4.62 (vs kr1.27 in FY 2019)

New 90-day high: kr169

AddLife AB (publ) to Report Fiscal Year 2021 Results on Feb 03, 2022

New 90-day high: kr150

Insider recently bought kr692k worth of stock

AddLife AB (publ) (OM:ALIF B) completed the acquisition of the advanced surgery business of SIAD Healthcare S.p.A.

AddLife AB (publ) to Report Nine Months, 2021 Results on Oct 22, 2021

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Zafe Care Systems Ab.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Ropox A/S.

Análisis de compensación del CEO

CEO

Permanencia

Compensación